Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La RochefiledCriticalHoffmann La Roche
Publication of CH189753ApublicationCriticalpatent/CH189753A/de
C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
C07D239/60—Three or more oxygen or sulfur atoms
C07D239/62—Barbituric acids
Landscapes
Chemical & Material Sciences
(AREA)
Organic Chemistry
(AREA)
Medicinal Preparation
(AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
CH189753D1935-05-161936-04-17Verfahren zur Dosierung von N-methyl-C, C-allylisopropylbarbitursaurem Natrium.
CH189753A
(de)